As research continues, those involved say this would be a game changer, especially for patients with very limited options.

see our End of life care information. You can also call Alzheimer’s Society on 0333 150 3456 for personalised advice and support on living well with dementia, at any stage.

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

Supporting a person in the later stages of dementia The later stages of dementia ... Even though a person with dementia may end up sleeping more than a typical person of their age – even as much as 14 ...

Changes over time: Early stages cause mild loss of memory and other functions. Gradually, people lose the ability to live independently. By the end of their lives, people with Alzheimer’s need help ...

Correspondence to Dr Joseph Dimech, Department of Gerontology and Dementia Studies, Faculty for Social Wellbeing, University of Malta, Msida MSD2080, Malta; dimechjoseph{at}gmail.com Background ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...

The global population is progressively aging, to the extent that over 1.5 billion people worldwide will be aged 65 years or more by 2050, and the prevalence of end-stage renal disease in the ...

Research in August 2023 concluded that just a small percentage of older adults who are in the early stages of Alzheimer’s disease meet the ... To that end, scientists say blood tests are ...